Carcinoma, Non-Small-Cell Lung
"Carcinoma, Non-Small-Cell Lung" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
| Descriptor ID |
D002289
|
| MeSH Number(s) |
C04.588.894.797.520.109.220.249 C08.381.540.140.500 C08.785.520.100.220.500
|
| Concept/Terms |
Carcinoma, Non-Small-Cell Lung- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Non Small Cell Lung
- Carcinomas, Non-Small-Cell Lung
- Lung Carcinoma, Non-Small-Cell
- Lung Carcinomas, Non-Small-Cell
- Non-Small-Cell Lung Carcinomas
- Nonsmall Cell Lung Cancer
- Non-Small-Cell Lung Carcinoma
- Non Small Cell Lung Carcinoma
- Carcinoma, Non-Small Cell Lung
- Non-Small Cell Lung Cancer
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Non-Small-Cell Lung".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Non-Small-Cell Lung".
This graph shows the total number of publications written about "Carcinoma, Non-Small-Cell Lung" by people in this website by year, and whether "Carcinoma, Non-Small-Cell Lung" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 2 | 9 |
| 1996 | 4 | 0 | 4 |
| 1997 | 4 | 0 | 4 |
| 1998 | 10 | 1 | 11 |
| 1999 | 4 | 0 | 4 |
| 2000 | 5 | 2 | 7 |
| 2001 | 6 | 2 | 8 |
| 2002 | 6 | 1 | 7 |
| 2003 | 17 | 1 | 18 |
| 2004 | 8 | 1 | 9 |
| 2005 | 13 | 5 | 18 |
| 2006 | 14 | 4 | 18 |
| 2007 | 19 | 2 | 21 |
| 2008 | 17 | 4 | 21 |
| 2009 | 16 | 3 | 19 |
| 2010 | 19 | 3 | 22 |
| 2011 | 37 | 4 | 41 |
| 2012 | 26 | 0 | 26 |
| 2013 | 33 | 1 | 34 |
| 2014 | 21 | 4 | 25 |
| 2015 | 44 | 2 | 46 |
| 2016 | 37 | 3 | 40 |
| 2017 | 32 | 2 | 34 |
| 2018 | 43 | 4 | 47 |
| 2019 | 45 | 3 | 48 |
| 2020 | 53 | 2 | 55 |
| 2021 | 46 | 3 | 49 |
| 2022 | 40 | 0 | 40 |
| 2023 | 42 | 0 | 42 |
| 2024 | 30 | 2 | 32 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Non-Small-Cell Lung" by people in Profiles.
-
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2024 Dec; 8:e2400373.
-
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.
-
Breathing down resistance: Tackling hypoxia to overcome immunotherapy barriers in lung cancer. J Exp Med. 2025 Jan 06; 222(1).
-
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024 Nov; 635(8038):462-471.
-
Non-small-cell lung cancer. Nat Rev Dis Primers. 2024 Sep 26; 10(1):71.
-
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2024 Sep 28; 404(10459):1240-1252.
-
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society. J Thorac Oncol. 2024 Dec; 19(12):1640-1653.
-
Comparison of Measurement and Prognostic Power of SUV Between High-Definition and Standard PET Imaging in Non-Small Cell Lung Cancer Patients. J Nucl Med Technol. 2024 Sep 05; 52(3):229-233.
-
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial. JAMA Oncol. 2024 Sep 01; 10(9):1212-1219.
-
Recurrence of Non-Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2024 Sep 01; 10(9):1179-1186.